2018-04-17

[#DIV28SUPER] Chair Search-University of Kentucky Department of Behavioral Science

Department of Behavioral Science
Department Chair

The College of Medicine seeks a dynamic academic and research driven innovative leader to serve as its next Chair for the Department of Behavioral Science and invites applications for the position.

This is a unique opportunity to build upon a strong and diverse foundation to substantially impact the behavioral health challenges facing the Commonwealth of Kentucky and beyond. Therefore, we desire a visionary Chair with an understanding of the future of behavioral science for the Commonwealth and demonstrated leadership abilities.

History
The Department of Behavioral Science (BSC) at the University of Kentucky College of Medicine was founded in 1959 by William R. Willard, MD, the medical school's first dean, and was the first of its kind in the United States. The department's first Chair was Robert Straus, PhD, who was also a member of the founding committee for the medical center.

Although unique at the time, the decision to enhance the behavioral science content of medical education now has become an established priority for NIH and the Institute of Medicine. Behavioral scientists in most medical schools, though, are still either scattered throughout clinical departments, located in medical education units, or are placed in divisions within Departments of Psychiatry. As a free-standing basic science department, BSC is an academic teaching and research unit, administratively independent, but with strong collaborative ties to clinical departments and to other basic science departments.
The department is multidisciplinary, with 33 Faculty Appointments across the disciplines of experimental psychology, social psychology, clinical psychology, cognitive neuroscience, behavioral pharmacology, epidemiology, anthropology, psychiatry, pediatrics, ethics history, pharmacology, sociology, and social work. Strong areas of research within the department include Drug Abuse, Oncology and Aging, among others. Departmental faculty members collaborate with many other academic departments in the College of Medicine and across the University. Having responsibility for "Introduction to Clinical Medicine," the department has a primary role in medical student education. Additionally, Behavioral Science faculty members also teach in the College of Dentistry and the Honors College. Graduate education includes an interdisciplinary certificate, master's degree, and doctoral degree in clinical and translational science.

Qualifications
A successful candidate should be recognized for exceptional accomplishments as a researcher and academician in a behavioral science field. Additionally, the candidate will have a strong record of administrative experience as a department chair, division chief or program/center director; and ability to serve as a listener, decision-maker, humanist, servant leader, and effective advocate for the Department of Behavioral Science and its faculty.

Furthermore, the candidate should collaborate effectively; possess the desire to learn and share; and should have people-skills that promote, foster, and facilitate the trust of colleagues, the broader University, and those who might make philanthropic gifts to the University. The Chair should have impeccable integrity; be an effective and able communicator; be nationally/internationally recognized for achievement in research, educational, and service pursuits that would warrant appointment as a full professor; demonstrate upward movement in leadership or administrative positions in medical school or academic medical center setting; and have a proven record of recruitment and retention of talented faculty and staff, as well as mentorship of faculty, staff and trainees.

Reporting to the dean of UK College of Medicine, Robert S. DiPaola, MD, the Chair serves as the chief academic and administrative officer for the department. The Chair will have the opportunity to significantly enhance the academic and research missions of the department, to build upon its partnerships within UK Healthcare, the University, and with numerous external partners.

Education
Terminal degree in a behavioral science field (e.g., psychology, behavioral science, social science, sociology, etc.) with a sustained record of scholarly activity.

How to Apply
Candidates should apply online at http://ukjobs.uky.edu/postings/179325 with a curriculum vita and letter of interest. Applications will be reviewed immediately, and applications will be accepted until the position is filled.
ukjobs.uky.edu
The University of Kentucky is seeking a Chair of Behavioral Science for an exciting opportunity to promote growth and development of research and teaching excellence of the Department, as well as oversee research, education, and other departmental activities. This Chair will work closely with the Department's Faculty, the Dean and senior leadership within the College and University to implement a strategic plan for the Department. The Chair must also foster and support research in alignment with the vision and mission of the University, oversee the continuing education of the Department's faculty and overall educational mission. The Chair serves as an important spokesperson for UK's Behavioral Sciences Department research, service, and educational activities at the local, regional and national level. Applications will be reviewed immediately, and will continue until the position is filled. Please include a CV and cover letter along with application.

Upon offer of employment, successful applicants must undergo a national background check and pre-employment drug screen as required by University of Kentucky Human Resources. The University is an equal opportunity employer and encourages applications from minorities and women.


               
---------------------------------------------------------------------------------
William W. Stoops, Ph.D.
email: william.stoops@uky.edu
phone: (859) 257-5383
facsimile: (859) 257-7684


Professor
University of Kentucky College of Medicine
Department of Behavioral Science
Department of Psychiatry
Center on Drug and Alcohol Research
University of Kentucky College of Arts and Sciences
Department of Psychology

Director
Regulatory Knowledge and Support Core
Component Lead
Research Methods
University of Kentucky Center for Clinical and Translational Science

STATEMENT OF CONFIDENTIALITY
The contents of this e-mail message and any attachments are confidential and are intended solely for the addressee. The information may also be legally privileged. This transmission is sent in trust, for the sole purpose of delivery to the intended recipient. If you have received this transmission in error, any use, reproduction or dissemination of this transmission is strictly prohibited. If you are not the intended recipient, please immediately notify the sender by reply e-mail or at (859) 257-5383 and delete this message and its attachments, if any.

2018-04-12

[#DIV28SUPER] VA Medicinal Cannabis Research Act of 2018

Dear Div 28 Members,

The leadership of the House Committee on Veterans Affairs is seeking organizational and individual endorsements of a bill (attached) to urge new research by the VA into the health impact of cannabis use among veterans. APA is endorsing the bill and is leading the effort to secure additional organizational endorsements through the Friends of NIDA coalition but interested scientists and clinicians can also provide their support for this bill by signing here.

https://www.surveygizmo.com/s3/4308838/VA-Medicinal-Cannabis-Research-Act-of-2018-sign-on

Hope everyone is doing well.
Regards,

-Ryan

___________________
Ryan Vandrey, Ph.D.
Associate Professor
Behavioral Pharmacology Research Unit
Johns Hopkins University School of Medicine
5510 Nathan Shock Dr.
Baltimore, MD 21224
410-550-4036 (phone)
410-550-0030 (fax)


2018-04-10

[#DIV28SUPER] interesting article on big pharma donations

https://www.medscape.com/viewarticle/894909?nlid=121761_1521&src=WNL_mdplsfeat_180410_mscpedit_wir&uac=119841BR&spon=17&impID=1604155&faf=1


In case you had not seen this on medscape today you may find it interesting.  Presents information from Kaiser Health on big pharma donations to different groups.
Clicking on the link describing "patient advocacy groups" reveals a database of who got money.

Again, may be of interest -
Nancy


Nancy A. Piotrowski, Ph.D.
Core Faculty & Lead, Addiction Psychology
Harold Abel School of Social of Psychology
Capella University
 
Federal Advocacy Coordinator, Div50, American Psychological Association

Membership Chair, Div34, American Psychological Association
President, Napa Solano Psychological Association
 
MAIL:  P.O. Box 5525, Vallejo, California 94591-0552
With Offices in the San Francisco Bay Area
Text or Message:  707.561.2358
Call or Message:  415.386.4923
FAX by request
 
Email:              napiotrowski@yahoo.com
ALT Email:       PiotrowskiConsultation@gmail.com
Skype:             napiotrowski
 

IMPORTANT NOTICE: This transmission and any attachments are intended only for the individual or entity to which it is addressed and may contain information that is privileged, confidential or exempt from disclosure under applicable federal or state laws.  If the reader of this transmission is not the intended recipient, you are hereby notified that any use, dissemination, distribution or copying of this communication, without explicit written communication to handle otherwise, is strictly prohibited.  If you have received this transmission in error, please notify me immediately by email.



[#DIV28M] interesting article on big pharma donations

https://www.medscape.com/viewarticle/894909?nlid=121761_1521&src=WNL_mdplsfeat_180410_mscpedit_wir&uac=119841BR&spon=17&impID=1604155&faf=1


In case you had not seen this on medscape today you may find it interesting.  Presents information from Kaiser Health on big pharma donations to different groups.
Clicking on the link describing "patient advocacy groups" reveals a database of who got money.

Again, may be of interest -
Nancy


Nancy A. Piotrowski, Ph.D.
Core Faculty & Lead, Addiction Psychology
Harold Abel School of Social of Psychology
Capella University
 
Federal Advocacy Coordinator, Div50, American Psychological Association

Membership Chair, Div34, American Psychological Association
President, Napa Solano Psychological Association
 
MAIL:  P.O. Box 5525, Vallejo, California 94591-0552
With Offices in the San Francisco Bay Area
Text or Message:  707.561.2358
Call or Message:  415.386.4923
FAX by request
 
Email:              napiotrowski@yahoo.com
ALT Email:       PiotrowskiConsultation@gmail.com
Skype:             napiotrowski
 

IMPORTANT NOTICE: This transmission and any attachments are intended only for the individual or entity to which it is addressed and may contain information that is privileged, confidential or exempt from disclosure under applicable federal or state laws.  If the reader of this transmission is not the intended recipient, you are hereby notified that any use, dissemination, distribution or copying of this communication, without explicit written communication to handle otherwise, is strictly prohibited.  If you have received this transmission in error, please notify me immediately by email.



2018-04-09

[#DIV28M] APA Division 28 Seeking Nominations for New Fellows

Dear Colleagues:

The American Psychological Association (APA) Division on Psychopharmacology and Substance Abuse (Division 28) is seeking nominations for new Fellows. As described by APA, "Fellow status is an honor bestowed upon APA members who have shown evidence of unusual and outstanding contributions or performance in the field of psychology. Fellow status requires that a person's work has had a national impact on the field of psychology beyond a local, state, or regional level. A high level of competence or steady and continuing contributions are not sufficient to warrant fellow status. National impact must be demonstrated."

In Division 28 a successful nominee will typically be 10+ years post-doctorate, have a track record of substantial external funding and publication productivity, and can document the national impact of their research on the psychopharmacology and substance abuse fields.

If you would like to nominate a colleague for consideration for Fellow status, please send their CV and contact information to the address below. You may also nominate somebody who is already an APA Fellow (with relevance to our Division), but who is not yet a Fellow of Division 28. Self-nominations are also welcomed.

Contact Information for Fellow Nominations:

Adam Leventhal, Ph.D.
adam.leventhal@usc.edu
APA Division 28 Fellows Chair

Don't hestitate to contact me if you had any further questions.

Best,

Adam
--
Adam Leventhal, Ph.D.
Director, USC Health, Emotion, & Addiction Laboratory
Professor of Preventive Medicine and Psychology
USC Norris Comprehensive Cancer Center
Keck School of Medicine
University of Southern California
2250 Alcazar St., CSC 271
Los Angeles, CA 90033
Phone: 323-442-8222
Fax: 323-442-2359
heal.usc.edu

_____________________________ div28m@lists.apa.org
restricted to APA members list archive
twitter: @apadiv28

2018-04-06

[#DIV28SUPER] ADHD Research Awards 2018 – Applications Now Available

ADHD Research Awards 2018 – Applications Now Available

 

CHADD (Children and Adults with Attention-Deficit/Hyperactivity Disorder) is pleased to announce the 2018 Young Scientist Research Awards, a program to recognize emerging researchers making contributions to the understanding of ADHD. 

 

Two awards will each include an unrestricted cash prize of $1,000, recognition at the 2018 Annual International Conference on ADHD in St. Louis, Missouri; conference travel; registration and expense allowance; a one-year professional membership to CHADD; and recognition in CHADD's Attentionmagazine and on CHADD's website.  Applicants must be in the process of completing a doctoral degree or have completed one within the last three years with the doctoral degree awarded no earlier than January 2015.

 

Research may address any area relevant to ADHD including, but not limited to: biological/genetic underpinnings of the disorder; treatment efficacy; impact on the individual or family; school or workplace accommodations; social stigma and discrimination; public health; and epidemiology.

 

The awards are currently being supported by a number of individual donations.

 

Deadline for applications is May 21, 2018.  For an application or for more information, go towww.chadd.org/youngscientist or send an email toyoungscientist@chadd.org.  

 

 

Thank you very much.

 

 

Ms. Zuali Malsawma, MLS

YSRA Program Manager / Health Sciences Librarian

National Resource Center on ADHD: A Program of CHADD

4601 Presidents Drive, Suite 300

Lanham, MD 20706

240-487-2330 (direct)

800-233-4050 x130 (main)

www.help4adhd.org/nrc / www.chadd.org/nrc



Sent from my iPhone

2018-04-02

[#DIV28SUPER] FW: CDC Request for Assistance with Medication Assisted Treatment Study

Esteemed Colleagues –

 

Please see this call for assistance from our friends at the CDC.  They are conducting an epidemiological cohort study on Medication Assisted Treatment for opioid use disorder in real-world outpatient settings.  Please see below for treatment areas and geographic locations of particular need.

 

All best,

Mark

President, Division 28

 

From: "Fisher, Craig" <cfisher@apa.org>
Date: Monday, April 2, 2018 at 2:21 PM
Subject: CDC Request for Assistance with Medication Assisted Treatment Study

 

Our colleagues at the CDC's National Center for Injury Prevention and Control (NCIPC; aka the Injury Center) recently reached out to us looking for assistance.  They are conducting a mixed-methods study of Medication Assisted Treatment (MAT) in real-world outpatient settings. The purpose of this epidemiologic cohort study is to assess the type of MAT (methadone; buprenorphine; naltrexone; or counseling only, no-MAT), and the contextual, provider, and individual factors that influence implementation and improved patient well-being with 3,560 patients over a 2 year follow up period (regardless of retention in treatment). Only a few studies are available to help patients and providers make informed decisions about the long-term risks and benefits associated with the different types of treatment for opioid use disorder. Through this study they hope to learn more about the outcomes associated with different types of treatment and how these outcomes differ over time, and by patient (co-occurring conditions, employment, catalyst for treatment, etc.), provider, and site characteristics.

 

They are currently trying to recruit sites to participate in several different Metropolitan Services Areas (MSAs). They are particularly looking to recruit sites that provide counseling-only treatment for opioid use disorder in these metropolitan areas: (Los Angeles, San Francisco, Chicago, Cleveland, Cincinnati, Dallas/Ft. Worth, Seattle).  They were wondering if we could assist with any suggestions or contacts in any of these areas.

 

If you or your members can be of any assistance, please reach out directly to Marci Hertz, M.S., Lead Health Scientist in CDC's National Center for Injury Prevention and Control (NCIPC) at 770-488-2547 or mvf4@cdc.gov; or if you prefer I can help make the connection.

 

Thanks.

 

Craig D. Fisher, Psy.D.

Senior Legislative and Federal Affairs Officer

Science Government Relations

American Psychological Association

750 First Street NE, Washington, DC 20002-4242

Tel: 202.336.5762 |  Fax: 202.336.6063

cfisher@apa.org  | www.apa.org